Discontinued — last reported Q2 '24
Sleep and Respiratory Care — Operating Income (Loss)
ResMed Sleep and Respiratory Care — Operating Income (Loss) decreased by 10.5% to $408.36M in Q2 2024 compared to the prior quarter. Year-over-year, this metric grew by 23.6%, from $330.50M to $408.36M. Over 2 years (FY 2022 to FY 2024), Sleep and Respiratory Care — Operating Income (Loss) shows an upward trend with a 14.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher values indicate improved operational efficiency, better cost management, or stronger product margins.
Detailed definition
Measures the profitability of the sleep and respiratory care segment by subtracting operating expenses, including cost o...
Peer comparison
A standard profitability metric across all industries; peers report this as 'Segment Operating Income' or 'Segment Profit'.
rmd_segment_sleep_and_respiratory_care_operating_income_lossHistorical Data
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $297.22M | $282.56M | $267.81M | $432.00M | $352.56M | $373.37M | $390.70M | $330.50M | $390.42M | $426.39M | $456.18M | $408.36M |
| QoQ Change | — | -4.9% | -5.2% | +61.3% | -18.4% | +5.9% | +4.6% | -15.4% | +18.1% | +9.2% | +7.0% | -10.5% |
| YoY Change | — | — | — | — | +18.6% | +32.1% | +45.9% | -23.5% | +10.7% | +14.2% | +16.8% | +23.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's sleep and respiratory care — operating income (loss)?
- ResMed (RMD) reported sleep and respiratory care — operating income (loss) of $408.36M in Q2 2024.
- How has ResMed's sleep and respiratory care — operating income (loss) changed year-over-year?
- ResMed's sleep and respiratory care — operating income (loss) increased by 23.6% year-over-year, from $330.50M to $408.36M.
- What is the long-term trend for ResMed's sleep and respiratory care — operating income (loss)?
- Over 2 years (2022 to 2024), ResMed's sleep and respiratory care — operating income (loss) has grown at a 14.6% compound annual growth rate (CAGR), from $1.28B to $1.68B.
- What does sleep and respiratory care — operating income (loss) mean?
- The profit earned from core business operations before interest and taxes.